0102030405
Sofosbuvir Intermediates CAS NO 5442-91-1 Pharmaceutical Intermediates
02
introduce
4-(ETHOXYCARBONYL)-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID is a pyrrole derivative characterized by its unique molecular structure. The molecular formula is C10H13NO4, and it has a molecular weight of approximately 211.21 g/mol.
02
Physical and chemical properties
Appearance: The compound typically appears as a white to off-white crystalline powder.
Solubility: 4-(ETHOXYCARBONYL)-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID is soluble in organic solvents such as methanol and ethanol, while exhibiting limited solubility in water. This solubility profile enhances its utility in various pharmaceutical formulations.
Melting Point: The melting point of this compound is around 120-125°C, contributing to its stability during storage and handling.
Chemical Structure: The presence of the ethoxycarbonyl and dimethyl groups in the structure enhances its reactivity, making it a valuable intermediate in organic synthesis.
1. Key Intermediate for Drug Development: This compound is essential in the synthesis of various pharmaceutical compounds, particularly those targeting metabolic disorders and other therapeutic areas. Its unique structure allows for the development of innovative therapeutic agents.
2. Enhanced Reactivity: The chemical structure of 4-(ETHOXYCARBONYL)-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID increases its reactivity, making it a versatile building block in organic synthesis. This reactivity is beneficial for creating complex molecules in drug development.
3. Safety Profile: Clinical studies have shown that 4-(ETHOXYCARBONYL)-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID exhibits a favorable safety profile, making it a preferred choice for pharmaceutical applications. Its low toxicity levels contribute to its suitability for use in drug formulations.
4. Customizable Production: Our integrated manufacturing capabilities allow us to offer 4-(ETHOXYCARBONYL)-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID in various formulations tailored to meet specific client needs, whether for bulk orders or specialized applications.
5. Cost-Effective Solutions: By streamlining our production and trading processes, we can offer competitive pricing without compromising on quality. This makes 4-(ETHOXYCARBONYL)-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID an attractive option for pharmaceutical companies looking to optimize their production costs.
4-(ETHOXYCARBONYL)-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID is widely utilized in the pharmaceutical industry, particularly in the development of innovative drugs targeting metabolic disorders and other therapeutic areas. Its primary applications include:
- Synthesis of Active Pharmaceutical Ingredients (APIs): This compound serves as a critical intermediate in the production of APIs, which are the active components in various medications. Its role in the synthesis of APIs is vital for the development of effective therapeutic agents.
- Research and Development: Our high-quality 4-(ETHOXYCARBONYL)-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID is also available for research purposes, supporting the development of new formulations and therapeutic strategies. Researchers can utilize this compound to explore new drug candidates and optimize existing formulations.
- Formulation Development: Pharmaceutical companies can use this compound to create various dosage forms, including tablets, capsules, and injectable solutions. Its solubility and stability make it an ideal candidate for diverse pharmaceutical applications.
In conclusion, 4-(ETHOXYCARBONYL)-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID is a versatile pharmaceutical intermediate with significant advantages for drug development. Our commitment to quality, regulatory compliance, and customer satisfaction makes us a trusted partner in the pharmaceutical industry. Choose 4-(ETHOXYCARBONYL)-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID for your next formulation and experience the benefits of our integrated manufacturing solutions. With our expertise and dedication, we are here to support your pharmaceutical innovations and contribute to better health outcomes.